Litigation Follows OTC Eye Drops Recall Due To Bacteria Strain Not Previously Seen In US

Complaints Against EzriCare, Delsam, Aru Pharma Follow US Warning To Manufacturer In India

21 Feb 2023

• By Lauren Nardella

Following a recall earlier in February of EzriCare’s and Delsam’s OTC artificial tears due to potential bacterial contamination, plaintiffs’ bar steps in with first of what may be multiple lawsuits. CDC says drug-resistant strain of Pseudomonas aeruginosa bacteria not previously seen in US.

Less than a month after a recall of their OTC artificial tear eye drops began, EzriCare LLC and Delsam Pharma LLC are targeted in litigation alleging harm from a bacterial contamination experts say has not previously been found in the US.

The Food and Drug Administration on 2 February announced a voluntary recall of OTC artificial tear products formulated with carboxymethylcellulose made by Indian firm Global Pharma Healthcare Private Ltd